Table 3.
Outcomes from control (SOC) treatment of 15 mild COVID-19 patients (N = 60)
| Variables | Days of admission (mean ± SD) | 7 days after admission (mean ± SD) | 14 days after admission (mean ± SD) | p-values (days: 1, 7) | p-values (days: 7, 14) |
|---|---|---|---|---|---|
| RBS (mmol/L) | 7.313 ± 3.634 | 7.313 ± 3.634 | 7.388 ± 3.395 | 0.5000, 1.0000 |
0.4493, 0.8986 |
| WBC (K/µL) | 14.347 ± 12.171 | 23.800 ± 17.921 | 19.733 ± 5.257 | 0.0002**, 0.0004** |
0.1976, 0.3953 |
| Neutrophil (%) | 64.467 ± 11.874 | 97.867 ± 13.522 | 80.067 ± 27.215 | 0.0000**, 0.0000** |
0.0128**, 0.0257* |
| RBC (million/dL) | 5.185 ± 2.145 | 48.080 ± 163.493 | 6.042 ± 1.819 | 0.1635, 0.3270 |
0.1674, 0.3348 |
| Hemoglobin (g/dL) | 12.720 ± 1.543 | 15.435 ± 2.840 | 14.229 ± 2.116 | 0.0042**, 0.0085** |
0.1032, 0.2063 |
| Platelets (K/µL) | 192.267 ± 74.622 | 245.533 ± 109.744 | 256.333 ± 109.017 | 0.0789, 0.1578 |
0.2380, 0.4760 |
| S. Ferritin (ng/mL) | 183.060 ± 115.985 | 345.200 ± 102.482 | 115.600 ± 65.19 | 0.0000**, 0.0000** |
0.0000**, 0.0000** |
| CRP (mg/L) | 8.077 ± 11.46 | 19.800 ± 12.639 | 18.067 ± 4.284 | 0.0003**, 0.0007** |
0.3027, 0.6054 |
| D-dimer (µg/mL) | 0.471 ± 0.173 | 1.100 ± 0.774 | 0.508 ± 0.192 | 0.0053**, 0.0105** |
0.0067**, 0.0134** |
| O2 saturation at room air (%) at day 1 | 96.133 ± 1.060 | 91.133 ± 2.200 | 95.267 ± 1.100 | 0.0000**, 0.0000** |
0.0000**, 0.0000** |
COVID-19, coronavirus disease in 2019; CRP, C-reactive protein; O2, oxygen; RBC, red blood cell; RBS, random blood sugar; S. Ferritin, serum ferritin; SOC, standard of care; WBC, white blood count. Data are shown as mean ± standard deviation. Statistical significance was considered when p-value was <0.01 and <0.05 and shown as ** and * mark, respectively. p value = normal value one-tail and bold value two-tail, calculated with 5% level of significance